Trevogrumab (REGN1033) is an antibody that binds to multiple forms of MSTN with high affinity and specificity, while avoiding closely related proteins such as GDF11 and activins, which also signal through activin type II receptors.[75] Another antibody that targets pro-MSTN and the latent form to inhibit the release of active MSTN is apitegromab (SRK-015).[76] The mature form of MSTN shares high similarity with other closely related TGF- family members, including GDF11, and activin receptors can bind a variety of ligands.[72] Therefore, inhibitors that target only mature MSTN or activin receptors may lead to undesirable off-target effects, as highlighted earlier
Mounjaro (tirzepatide) is a glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist licensed in the UK for the treatment of type 2 diabetes mellitus
These show why how to reconstitute peptides is rarely a one-size-fits-all procedure once sequences grow complex
The medication has demonstrated significant weight loss in clinical trials, with participants losing an average of 12-15% of their body weight over 68 weeks in the STEP clinical trial programme
Taylor Cottle, PhD Serial Biotech Entrepreneur| PhD, John Hopkins University
Do I need a prescription for lipotropic injections vs
